The gamma-glutamyl transpeptidase to platelet ratio (GPR) and the gamma-glutamyl transpeptidase to albumin (GAR) versus fibroscan as indicators of hepatic fibrosis in Non-Alcoholic Fatty Liver Disease Patients
soliman, S., Badawi, R., Elkhalawany, W. (2023). The gamma-glutamyl transpeptidase to platelet ratio (GPR) and the gamma-glutamyl transpeptidase to albumin (GAR) versus fibroscan as indicators of hepatic fibrosis in Non-Alcoholic Fatty Liver Disease Patients. EKB Journal Management System, 6(1), 106-117. doi: 10.21608/ajgh.2023.218534.1035
samah soliman; Rehab Badawi; Walaa Elkhalawany. "The gamma-glutamyl transpeptidase to platelet ratio (GPR) and the gamma-glutamyl transpeptidase to albumin (GAR) versus fibroscan as indicators of hepatic fibrosis in Non-Alcoholic Fatty Liver Disease Patients". EKB Journal Management System, 6, 1, 2023, 106-117. doi: 10.21608/ajgh.2023.218534.1035
soliman, S., Badawi, R., Elkhalawany, W. (2023). 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) and the gamma-glutamyl transpeptidase to albumin (GAR) versus fibroscan as indicators of hepatic fibrosis in Non-Alcoholic Fatty Liver Disease Patients', EKB Journal Management System, 6(1), pp. 106-117. doi: 10.21608/ajgh.2023.218534.1035
soliman, S., Badawi, R., Elkhalawany, W. The gamma-glutamyl transpeptidase to platelet ratio (GPR) and the gamma-glutamyl transpeptidase to albumin (GAR) versus fibroscan as indicators of hepatic fibrosis in Non-Alcoholic Fatty Liver Disease Patients. EKB Journal Management System, 2023; 6(1): 106-117. doi: 10.21608/ajgh.2023.218534.1035